Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | BIPIX Insights | BIPIX Score | BIPIX Performance | BIPIX News | BIPIX Allocation | BIPIX Holdings Change

ProFunds Biotechnology UltraSector Inv (BIPIX) Fund Ranking and Research

Ranking, Research and Recommendation of ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

    Last Trade: $54.40 on 4/21/2017, Change: -0.59 (-1.07%)

 

Graph of ProFunds Biotechnology UltraSector Inv Fund (BIPIX) ManagerFund Manager - Michael Neches

Fund Manager Information

Fund Manager Tenure: 3.6 years
Similar Funds: BIPSX 
Fund Family: ProFunds
Fund Category: Trading--Leveraged Equity
Fund Performance: May 30, 2016
Fundmojo Fund Grade: C (Score: 0.52)     (What does this score mean?)

 

Graph of ProFunds Biotechnology UltraSector Inv Fund (BIPIX) ProfileProFunds Biotechnology UltraSector Inv Fund (BIPIX) Profile

Fund Profile and Description

ProFunds Biotechnology UltraSector Inv Fund seeks daily investment results, before fees and expenses, that correspond to one and one-half times (150%) the daily performance of the Index. ProFunds Biotechnology UltraSector Inv Fund invests in equity securities and derivatives that ProFund Advisors believes, in combination, should have similar daily return characteristics as one and one-half times (150%) the daily return of the Index. Assets of the fund not invested in equity securities or derivatives will typically be held in money market instruments. It is non-diversified.

 

ProFunds Biotechnology UltraSector Inv (BIPIX) Fund Strength What we like about ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

Data for ProFunds Biotechnology UltraSector Inv Fund (BIPIX) as of May 30, 2016

  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) management has been with ProFunds Biotechnology UltraSector Inv Fund for 3.6 years
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) has good mid-term performance (3-year return 19.58% vs 10.54% Trading--Leveraged Equity category median performance)
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) has good Long-term performance (5-year return 31.85% vs 11.60% Trading--Leveraged Equity category median performance)
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) ratio of up-years vs down years is greater than 2
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) has a Morningstar rating of 4 and above
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) has an annual stock turnover rate of 11.00% vs Trading--Leveraged Equity average of 241.85%. It is good that ProFunds Biotechnology UltraSector Inv management does not trade extensively for its return.
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) has a lower expense ratio than its Trading--Leveraged Equity average: 1.52% vs 1.98%
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

ProFunds Biotechnology UltraSector Inv Fund (BIPIX) Weakness What we are cautious about ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

Data for ProFunds Biotechnology UltraSector Inv Fund (BIPIX) as of May 30, 2016

  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) has a less-than-ideal short-term performance (1-year return -25.87% vs -4.19% Trading--Leveraged Equity category median performance)
  • ProFunds Biotechnology UltraSector Inv Fund (BIPIX) is less safe compared to its Trading--Leveraged Equity peers
See ProFunds Biotechnology UltraSector Inv Fund (BIPIX) performance details as of May 30, 2016

 

What do you think?

 

Compare ProFunds Biotechnology UltraSector Inv Fund (BIPIX)Compare with other top Trading--Leveraged Equity category mutual funds

Aadditional top Trading--Leveraged Equity mutual funds for your consideration

FundYear to Date1 Year3 year5 year
ProFunds Biotechnology UltraSector Inv-16.65-25.8719.5831.85
Direxion Mthly NASDAQ-100 Bull 2X Inv (DXQLX)-4.14-2.5729.7727.11Compare

See top fund managers for Trading--Leveraged Equity Category Funds

 

Compare ProFunds Biotechnology UltraSector Inv Fund (BIPIX)Compare with Trading--Leveraged Equity category ETFs

Some Trading--Leveraged Equity ETFs for your consideration

ETFYear to DateOne YearThree Year
Direxion Daily Real Estate Bull 3X ETF (DRN)13.32%19.52%21.10%
ProShares Ultra Real Estate (URE)9.51%13.61%14.57%
ProShares Ultra Consumer Goods (UGE)5.96%11.59%20.27%
ProShares Ultra Consumer Services (UCC)000
ProShares Ultra Dow30 (DDM)000

 

Graph of ProFunds Biotechnology UltraSector Inv Fund (BIPIX) Net Asset TrackingProFunds Biotechnology UltraSector Inv (BIPIX) Fund Net Asset

Track net asset change of ProFunds Biotechnology UltraSector Inv fund (BIPIX)

DateNet Asset
05/2016$434.82M
03/2016$410.81M
02/2016$448.78M
More historic net asset information on ProFunds Biotechnology UltraSector Inv Fund (BIPIX)

  

Graph of ProFunds Biotechnology UltraSector Inv Fund (BIPIX) Portfolio TrackingProFunds Biotechnology UltraSector Inv (BIPIX) Fund Portfolio Allocation

Track portfolio allocation change of ProFunds Biotechnology UltraSector Inv fund (BIPIX)

DateCashStockBondOther
01/201628.9%71.08%0%0%
10/201523.02%74.1%0%2.88%
07/201534.15%65.85%0%0%
Click here to see more historic asset allocation information on ProFunds Biotechnology UltraSector Inv Fund (BIPIX)

 

graph of ProFunds Biotechnology UltraSector Inv Fund (BIPIX) Top 10 Position TrackingTop 10 Holdings in ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

Discover what ProFunds Biotechnology UltraSector Inv Fund (BIPIX) manager is buying

Jan 30, 2016
Gilead Sciences, Inc. [12.26%]
Amgen Inc. [11.8%]
AbbVie Inc. Common Stock [9.19%]
Celgene Corporation [8.07%]
Biogen Inc. [6.24%]
Alexion Pharmaceuticals, Inc. [3.37%]
Regeneron Pharmaceuticals, Inc. [3.34%]
Illumina, Inc. [2.37%]
Vertex Pharmaceuticals Incorpor [2.28%]
Baxalta Incorporated Common Sto [2.22%]

Oct 30, 2015
Gilead Sciences, Inc. [14.09%]
Amgen Inc. [10.65%]
AbbVie Inc. Common Stock [8.75%]
Celgene Corporation [8.61%]
Biogen Inc. [5.75%]
Regeneron Pharmaceuticals, Inc. [3.83%]
Alexion Pharmaceuticals, Inc. [3.53%]
Vertex Pharmaceuticals Incorpor [2.71%]
Illumina, Inc. [1.84%]
Incyte Corporation [1.71%]

Jul 30, 2015
Gilead Sciences, Inc. [12.8%]
Amgen Inc. [9.92%]
AbbVie Inc. Common Stock [8.9%]
Celgene Corporation [7.69%]
Biogen Inc. [5.54%]
Alexion Pharmaceuticals, Inc. [3.27%]
Regeneron Pharmaceuticals, Inc. [3.09%]
Vertex Pharmaceuticals Incorpor [2.43%]
Illumina, Inc. [2.34%]
BioMarin Pharmaceutical Inc. [1.73%]
Click here for Stock Holding Change Map in ProFunds Biotechnology UltraSector Inv Fund (BIPIX)

  

Latest News on ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

See what is happening with ProFunds Biotechnology UltraSector Inv Fund (BIPIX)

    No recent news

 

ProFunds Biotechnology UltraSector Inv Fund (BIPIX) Related ResourcesSee more information on ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

Popular pages on ProFunds Biotechnology UltraSector Inv (BIPIX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update